Beyond Covid-19: innovations in vaccine technologies. The race is on.

Posted on: 09/07/2020

Covid-19 has been devastating. The pandemic continues to leave a trail of devastation in its wake with tragically high death rates, wrecked lives and livelihoods and billions forced to change their plans for the future. An effective vaccine may well be our only hope of a return to something resembling normality.

Across the globe, the race is on to develop and produce high volumes of vaccines quickly. The UK government has put together a Taskforce to coordinate Covid-19 vaccine efforts. Two teams are currently leading the charge: The University of Oxford with an adenovirus-based vaccine candidate and Imperial College London with a self-amplifying RNA vaccine candidate. However, we shouldn’t forget that there is also an ecosystem within the UK of innovative, exciting companies who are developing vaccine-enabling technologies that will enable a better response to Covid-19 challenges and beyond.

KTN Beyond Covid-19: innovations in vaccine technologies webcast, 29 July, 14:00-15:30

Join KTN and the Medicines Manufacturing Challenge Community to find out how some of those UK companies are developing game-changing enabling technologies in vaccine formulation, manufacture and delivery.

The session will hear from Steve Bagshaw, Chairman of Fujifilm Diosynth Biotechnologies, and Supply Chain Workstream Lead of the BIA Vaccine Manufacturing Taskforce, who will set the scene and describe how the UK’s vaccines sector is responding to the pandemic challenges.

Steve will be followed by short presentations from five innovative UK businesses who are breaking new ground in the development of enabling technologies, designed to accelerate vaccine development, production and delivery.  There will then be an opportunity for Q&A.

There will also be a session on innovation funding for UK businesses who work in biomedical research and development.

Showcase companies

Croda Europe Ltd, novel adjuvant technology



Aqdot Limited

Enesi Pharma, ImplaVax vaccine platform

This webcast is part of the ‘Beyond Covid-19’ series that KTN is hosting on various sectors where there have been fundamental changes, considering at what the future might look like and how innovation can play a part in the bounce back. There are links below to the recordings of those that have taken place.

Book a place on the webcast here.

Share this article


Connect with Innovate UK Business Connect

Join Innovate UK Business Connect's mailing list to receive updates on funding opportunities, events and to access Innovate UK Business Connect's deep expertise. Please check your email to confirm your subscription and select your area(s) of interest.